Winston-Salem, NC – According to filings with the U.S. Securities and Exchange Commission, Javara is raising $47,500,003.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jennifer Byrne played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Javara

Javara partners with large healthcare organizations in local communities across the country to integrate clinical research into clinical care and we are transforming healthcare and changing lives by connecting the right patients to the right trials at the right time. Javara is a Hindi word for tide. Just as tides rise and fall, research has successes and failures. But tides are resilient, too. In the same way, we relentlessly chip away at the bedrock of disease in our pursuit of finding new cures, improving patient outcomes and advancing world health. With a commitment to research and an innovative approach to clinical trials, we will begin to speak of more and more diseases in the past tense. We simply believe that clinical research should be a realistic option for as many patients as possible from the moment of diagnosis. CRAACO connects patients with clinical trials as part of their routine healthcare experience, expanding access to treatment options that otherwise would have been unavailable.

To learn more about Javara, visit http://www.javararesearch.com/

Contact:
Jennifer Byrne, Chief Executive Officer
336-365-0538
jbyrne@javararesearch.com
https://www.linkedin.com/in/jenniferjbyrne/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved